Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.

Nikolaj Torp Mads IsraelsenMinneke CoenraadMaria PappDebbie ShawcrossMarko KorenjakPaolo AngeliWim LalemanAdria JuanolaPere GinesJonel TrebickaAleksander Kragnull null

Published in: BMJ open (2024)

NCT05056220 EU CT: 2022-501006-34-01.

Keyphrases

clinical trial
study protocol
phase iii
phase ii
open label
endothelial cells
double blind
randomized controlled trial
computed tomography
placebo controlled
contrast enhanced
induced pluripotent stem cells
cell free
dual energy